Abstract: To investigate the impact of obstructive sleep apnea (OSA) on long-term cardiovascular outcomes in patients with acute coronary syndrome (ACS). This is a single-center, prospective cohort study. Between June 2015 to January 2020, consecutive ACS patients hospitalized at Beijing Anzhen Hospital, Capital Medical University were enrolled. All patients underwent portable sleep breathing monitoring, and they were then divided into moderate/severe OSA group (apnea-hypopnea index (AHI)≥15 events/hour) and no/mild OSA group (AHI<15 events/hour). The primary endpoint was major adverse cardiac and cerebrovascular event (MACCE), defined as a composite of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, ischemia-driven revascularization and hospital admission for unstable angina or heart failure. MACCE were compared yearly by the log-rank test. Multivariable Cox regression analyses were performed to determine the independent predictors of MACCE. A total of 1 927 patients with ACS were enrolled, including 1 629 males (84.5%), aged (56.4±10.5) years. Moderate/severe OSA was present in 1 014 (52.6%) patients. Compared with no/mild OSA group, moderate/severe OSA group exhibited a higher body mass index (<0.05). Hypertension, prior PCI were more prevalent in moderate/severe OSA group (both <0.05). The difference of ACS category between the two groups was statistically significant (=0.021). The rate of patients who underwent PCI and the number of stents were higher in the moderate/severe OSA group. During a 5-year follow-up (median 2.9 years (IQR 1.5-3.6 years)), the cumulative incidence of MACCE was significantly higher in the moderate/severe OSA group than in the no/mild OSA group (34.0% vs. 24.0%, =1.346, 95% 1.100-1.646, log-rank =0.004). The cumulative incidence of MACCE remained statistically higher at 4 and 5 year in the moderate/severe OSA group as compared to the no/mild OSA group (33.3% vs. 22.9%, =1.397, 95% 1.141-1.710, log-rank =0.001; 34.0% vs. 24.0%, =1.341, 95% 1.096-1.640 log-rank =0.004, respectively). Multivariate analysis showed that moderate/severe OSA (=1.312, 95% 1.054-1.631, =0.015) was an independent predictor of long-term MACCE in ACS patients. Moderate/severe OSA is observed in more than 52% ACS patients. Moderate/severe OSA is an independent predictor of long-term MACCE.

Influence of Obstructive Sleep Apnea hypopnea Syndrome on Cardiovascular Risk Factors

Characteristics of Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea Syndrome

To Study on the Association Between the Carotid Intima-Media Thickness and Adult Obstructive Sleep Apnea Hypoventilation Syndrom

Obstructive Sleep Apnea Promotes Cardiovascular Risk In Hypertensive Populations: A Cross-Sectional Study

Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome

Influnce of Obstructive Sleep Apnea Hypopnea Syndrome to the Levels of Serum Uric Acid and Blood Lipid

Effects of obstructive sleep apnea on inflammatory markers in patients with acute coronary syndrome

Impact of obstructive sleep apnea on the long-term cardiovascular outcomes in patients with acute coronary syndrome

Lipid metabolism and plaque development of carotid artery in patients with obstructive sleep apnea-hypopnea syndrome

Influence of Continuous Positive Airway Pressure Treatment on Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

The impact of obstructive sleep apnea hypopnea syndrome on the changes of peripheral blood lymphocyte immunophenotype and C-reactive protein

Analysis on Correlation Between Obstructive Sleep Apnea Hypopnea and Metabolic Syndromes in Male Patients

Obstructive Sleep Apnea and Cardiovascular Risk in Chinese Population: a Meta-analysis

Research on Serum Amyloid A Protein Levels in Patients with Obstructive Sleep Apnea

Research on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome Complicated With Coronary Heart Disease and Inflammatory Factors, Glycolipid Metabolism, Obesity, and Insulin Resistance

Effect of Obstructive Sleep Apnea- Hypopnea Syndrome on Hypertension and Metabolism Disorder

Association Between Obstructive Sleep Apnea and Cardiovascular Diseases.

Study about the change of lipid metabolism in patients of obstructive sleep apneahypopnea syndrome

Obstructive Sleep Apnea and Cardiovascular Risk: Meta-analysis of Prospective Cohort Studies

Obstructive Sleep Apnea and Risk of Cardiovascular Disease and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies

Changes of serum myocardial enzymes and uric acid in patients with severe obstructive sleep apnea hypopnea syn-drome complicated with hypertension